Arax Advisory Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Buy
28,807
+26,473
+1,134% +$417K ﹤0.01% 1625
2026
Q1
$33.5K Sell
2,334
-9,346
-80% -$155K ﹤0.01% 1847
2025
Q4
$206K Sell
11,680
-13,018
-53% -$215K 0.01% 1031
2025
Q3
$388K Buy
+24,698
New +$347K 0.01% 1002
2024
Q4
Sell
-22
Closed -$368 2712
2024
Q3
$368 Hold
22
﹤0.01% 2445
2024
Q2
$262 Buy
+22
New +$251 ﹤0.01% 2420

Other funds holding SHC

Arax Advisory Partners's SHC Position: Q2 2026 in Review

Arax Advisory Partners increased its Sotera Health (SHC) stake by 1,134% in Q2 2026, buying an estimated $417K and bringing the position to 28,807 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Arax Advisory Partners first reported a position in SHC in Q2 2024 and has held it in 6 quarters since. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Arax Advisory Partners held 28,807 shares of Sotera Health worth $511K as of Q2 2026.
  • Arax Advisory Partners bought 26,473 Sotera Health shares in Q2 2026, an estimated $417K.
  • Sotera Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1625 holding.
  • Arax Advisory Partners first reported a position in Sotera Health in Q2 2024 and has held it in 6 quarters since.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.